Growth Factors and Parkinson’s Disease – Where Next?

Growth Factors and Parkinson’s Disease – Where Next?
“There is clear evidence that GDNF and related growth factors can restore the dopaminergic nigrostriatal pathway in several animal models of PD,” explained lead author Roger A. Barker, PhD, Cambridge Centre for Brain Repair, Department of Clinical Neuroscience and WT-MRC Cambridge Stem Cell Institute, Cambridge, UK. “However, this has yet to translate into a clinically meaningful and robust response in ... read more
Source: IOS PressPublished on 2020-06-04By Carmel McNamara